BKD
Brookdale Senior Living Inc.
NYSE · Healthcare · Medical - Care Facilities · US
$11.77
−1.42%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.0B | 3.1B | 3.0B | 2.9B | 2.7B |
| Cost of Revenue | 2.6B | 2.5B | 2.2B | 2.1B | 2.2B |
| Gross Profit | 435.2M | 645.0M | 807.4M | 744.7M | 513.9M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 188.3M | 349.9M | 386.6M | 384.5M | 333.9M |
| General & Admin Expense | 134.3M | 241.0M | 177.9M | 175.0M | 333.9M |
| Selling & Marketing Expense | 54.0M | 108.9M | 208.7M | 209.5M | — |
| Other Expenses | 133.8M | 278.0M | 374.3M | 341.8M | 222.7M |
| Total Operating Expenses | 322.1M | 627.9M | 760.9M | 726.3M | 556.6M |
| Cost and Expenses | 2.9B | 3.1B | 2.9B | 2.8B | 2.8B |
| Operating Income (EBIT) | 113.1M | 17.2M | 46.5M | 18.4M | (42.7M) |
| Non-Operating | |||||
| Interest Income | 13.0M | 12.4M | 19.2M | 23.1M | 6.9M |
| Interest Expense | 194.3M | 253.1M | 243.3M | 231.7M | 205.9M |
| Net Interest Income | (181.3M) | (240.7M) | (224.1M) | (208.6M) | (199.0M) |
| Other Non-Op Income/Expense | (247.4M) | (281.9M) | (243.9M) | (198.7M) | (197.2M) |
| Non-Operating Income (excl Interest) | 53.1M | 28.8M | (16.5M) | (8.2M) | (8.7M) |
| EBT (Pre-Tax Income) | (134.3M) | (264.7M) | (197.3M) | (180.3M) | (239.9M) |
| Income Tax Expense | 4.1M | (2.0M) | 4.6M | 8.8M | (1.6M) |
| Bottom Line | |||||
| Net Income | (138.3M) | (262.7M) | (201.9M) | (189.0M) | (238.4M) |
| Earnings from Cont. Ops | (138.4M) | (262.7M) | (202.0M) | (189.1M) | (238.3M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (138.3M) | (262.7M) | (201.9M) | (189.0M) | (238.4M) |
| Per Share | |||||
| Basic EPS | ($0.58) | ($1.11) | ($0.89) | ($0.84) | ($1.25) |
| Diluted EPS | ($0.58) | ($1.11) | ($0.89) | ($0.84) | ($1.25) |
| Revenue Per Share | $12.61 | $13.34 | $13.11 | $12.73 | $14.41 |
| Shares | |||||
| Basic Shares Outstanding | 239.1M | 234.3M | 227.5M | 225.2M | 190.5M |
| Diluted Shares Outstanding | 243.9M | 234.3M | 227.5M | 225.2M | 190.5M |
| Profitability Metrics | |||||
| EBITDA | 882.8M | 347.7M | 420.8M | 369.3M | 319.9M |
| D&A | 822.7M | 359.2M | 357.8M | 342.7M | 353.9M |
| EBIT | 60.0M | (11.6M) | 63.0M | 26.6M | (34.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026